Stay updated on Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    An NIH site-wide notice about terminology changes appears above the page, and the site revision advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:48:48.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The revision label in the footer changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-07T00:17:33.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content with a generic error page and site footer. This indicates an access issue rather than an update to the trial data.
    Difference
    20%
    Check dated 2026-09-22T23:56:10.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.6 to v3.7.0. This indicates an internal version update and does not modify the public content or functionality.
    Difference
    0.0%
    Check dated 2026-09-16T00:09:01.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    New Revision: v3.6.6 was added, and the Plain Language Summary along with Revision: v3.6.5 were removed. This reflects an update to the page's versioning and the accessible content presented to readers.
    Difference
    0.0%
    Check dated 2026-09-01T20:43:06.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    The page now includes an NIH grant/contract annotation for 2018 in the list of identifiers.
    Difference
    0.0%
    Check dated 2026-08-25T20:40:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.